Philip Ward

Articles by Philip Ward

A public-private research initiative between GSK, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute aims to harness the power of "big data" and genome sequencing to improve the success rate for discovering new medicines.

Children with cancer are being denied new drugs because European Union rules are allowing companies to conduct trials on certain drugs only in adults, according to experts from The Institute of Cancer Research in London.

The European Forum for Good Clinical Practice has a vital role to play in bringing together all stakeholders to work out how to discharge their responsibilities in the framework of the clinical trial protocol for the protection of each consenting participant

The lack of accurate and extensive data about the safety and effectiveness of a wide range of drugs in pregnancy has restricted the treatment of pregnant women and contributed to an underlying health problem over the past 20 years, according to an editorial published in the June issue of Drug and Therapeutics Bulletin (DTB).